Projekt

A randomized, multicenter, phase III open-label study of the efficacy and safety of Trastuzumab-MCC-DM1 vs. Capecitabine and Lapatinib in patients with HER2-positive locally advanced or metastatic breast cancer who have received prior Trastuzumab-based therapy

Abgeschlossen · 2009 bis 2011

Ruhstaller Thomas, Baumann Michael, Riniker Salome